Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Elizabeth M. Alfaro"'
Autor:
Carla L. Pennella, Tamara Muñoz Cassina, Jorge G. Rossi, Edgardo M. Baialardo, Patricia Rubio, María A. Deu, Luisina Peruzzo, Myriam R. Guitter, Cristian G. Sanchez de La Rosa, Elizabeth M. Alfaro, María S. Felice
Publikováno v:
Cancers; Volume 14; Issue 13; Pages: 3286
Children with Down syndrome (DS) are at an increased risk of developing clonal myeloproliferative disorders. The balance between treatment intensity and treatment-related toxicity has not yet been defined. We analyzed this population to identify risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e280da286610ca08a411053dab05ad2c
https://doi.org/10.3390/cancers14133286
https://doi.org/10.3390/cancers14133286
Autor:
Jorge Rossi, Edgardo M Baialardo, Patricia L. Rubio, María A. Deu, Cristian G. Sánchez La Rosa, Elizabeth M. Alfaro, Pedro Zubizarreta, Carla L Pennella, Maria S. Felice, Myriam Guitter, Cristina N. Alonso
Publikováno v:
Pediatric bloodcancerREFERENCES. 67(10)
Background Infant acute lymphoblastic leukemia (ALL) is an infrequent disease characterized by clinical and biological features related to poor prognosis. Adapted therapies were designed without a clear consensus regarding the best treatment options.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dde0359e3159181a96e4e5110f52557
https://pubmed.ncbi.nlm.nih.gov/32729239
https://pubmed.ncbi.nlm.nih.gov/32729239
Autor:
Maria S. Felice, Myriam Guitter, Pedro Zubizarreta, Cristian G. Sánchez La Rosa, Elizabeth M. Alfaro, Natalia Millan, María L. Galluzzo, Fernando Fiandrino
Publikováno v:
Journal of Pediatric Hematology/Oncology. 39:602-608
OBJECTIVE Prospective analysis of clinical characteristics and long-term treatment results of a pediatric cohort with Hodgkin lymphoma (HL) treated in a single institution with ABVD and restricted radiotherapy (RT). PATIENTS AND METHODS Between Septe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b14a56292fbdc7ca980234001cc6f390
https://doi.org/10.1097/mph.0000000000000943
https://doi.org/10.1097/mph.0000000000000943
Autor:
Gladys Gutierrez, Patricia L. Rubio, Myriam Guitter, Maria S. Felice, Marta S. Gallego, Carlos M. Figueroa Turienzo, María L. Galluzzo, Cristian G. Sánchez La Rosa, Pedro Zubizarreta, Natalia Millan, Viviana Herzovich, Walter Cacciavillano, Guillermo L. Chantada, Cristina N. Alonso, Adriana Rose, Fabiana Lubieniecki, Daniel Alderete, Elizabeth M. Alfaro, Jorge Rossi
Publikováno v:
Journal of Pediatric Hematology/Oncology. 39:e406-e412
Introduction Childhood acute leukemias (AL) and lymphomas achieve good survival rates. However, second neoplasms (SN) are a devastating event. Methods From August 1987 to December 2016, 34 of 3321 (1%) patients with diagnosis of AL or lymphoma develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61e5cfe6c5fa02c503eccae1c77c6bd2
https://doi.org/10.1097/mph.0000000000000971
https://doi.org/10.1097/mph.0000000000000971
Autor:
Carla L Pennella, Edgardo M Baialardo, Cristian G. Sánchez La Rosa, Maria S. Felice, Elizabeth M. Alfaro, Pedro Zubizarreta, Jorge Rossi, Cristina N. Alonso, Myriam Guitter, Natalia Millan
Publikováno v:
Archivos argentinos de pediatria. 116(4)
Children with Down syndrome (DS) more commonly have acute lymphoblastic leukemia (ALL) and a lower survival rate than those without Down syndrome (WDS). We analyzed the clinical, demographic, and biological characteristics and treatment response of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6151a0ec9b62bc9c2f000eab15315d0b
https://pubmed.ncbi.nlm.nih.gov/30016023
https://pubmed.ncbi.nlm.nih.gov/30016023
Autor:
Marta S. Gallego, Maria S. Felice, Jorge Rossi, Pedro Zubizarreta, Patricia L. Rubio, Mariela C. Coccé, Andrea Bernasconi, Myriam R. Guitter, Elizabeth M. Alfaro, Cristina N. Alonso, Silvia Eandi Eberle
Publikováno v:
Leukemialymphoma. 57(9)
Childhood acute myeloid leukemia (AML) achieves event-free-survival (EFS) rates of ∼50%. Double induction phase has been introduced for improving these results. Four consecutive protocols for AML treatment were evaluated to assess the impact of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8d6ce9de0a41a27d49e1751f78d082e
https://pubmed.ncbi.nlm.nih.gov/26734812
https://pubmed.ncbi.nlm.nih.gov/26734812
Autor:
Patricia L. Rubio, Jorge Rossi, Cristina N. Alonso, Marta S. Gallego, Elizabeth M. Alfaro, Maria S. Felice, Myriam R. Guitter, Andrea Bernasconi, Pedro Zubizarreta
Publikováno v:
Leukemia & Lymphoma. 52:1215-1221
Historically, t(1;19)(q23;p13.3) has been related to pre-B acute lymphoblastic leukemia (ALL) and associated with a poor prognosis. Current treatments have overcome this dismal outcome, but advantages in survival for the unbalanced group have been re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b830fe5b9bdd8a9d5a1afd354f5f1bb7
https://doi.org/10.3109/10428194.2011.565436
https://doi.org/10.3109/10428194.2011.565436
Autor:
Jorge Rossi, Myriam Guitter, Elizabeth M. Alfaro, Pedro Zubizarreta, Maria S. Felice, Marta S. Gallego, Marcelo Scopinaro, Cristina N. Alonso, Lidia Fraquelli
Publikováno v:
Pediatric Blood & Cancer. 57:47-55
Background Our aim was to compare two different schedules of maintenance in pediatric acute lymphoblastic leukemia (ALL) treated with a BFM-based therapy, in a randomized study: an Arm with 6-MP + MTX (with or without vincristine and dexamethasone pu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9dacde32397a025c28288c0dde0cb72
https://doi.org/10.1002/pbc.23097
https://doi.org/10.1002/pbc.23097
Autor:
Maria S. Felice, María del Pilar Corral, Elizabeth M. Alfaro, Cristina Baró, Francesc Solé, Cristina N. Alonso, Jorge Rossi, Olaya Villa, Marta S. Gallego
Publikováno v:
Pediatric Blood & Cancer. 50:651-654
We present a case of acute myeloblastic leukemia (AML-M2) with a complex t(8;21) translocation and additional acquired chromosomes yielding a hyperdiploid karyotype. AML1/ETO transcript was observed by reverse transcription-polymerase chain reaction.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df9acf9853a393e081e867f40b229b67
https://doi.org/10.1002/pbc.21192
https://doi.org/10.1002/pbc.21192
Autor:
Natalia Millan, Myriam Guitter, Andrea Montanari, Cristian G. Sánchez La Rosa, Maria S. Felice, Elizabeth M. Alfaro, Laura Galluzzo, Pedro Zubizarreta
Publikováno v:
Blood. 128:5361-5361
Background: Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) is a rare subtype of Hodgkin Lymphoma (HL) that represents approximately 5% of HL and discloses a distinct clinical-pathological features with an overall good prognosis. Treatment st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f4dbe5d5cdb94588c739ce5d1bf566c
https://doi.org/10.1182/blood.v128.22.5361.5361
https://doi.org/10.1182/blood.v128.22.5361.5361